Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Show other versions (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
פורמט:	Journal article
שפה:	English
יצא לאור:	2012

פריטים דומים

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
מאת: Gillies, R, et al.
יצא לאור: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
מאת: Findlay, J, et al.
יצא לאור: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
מאת: Gillies, R, et al.
יצא לאור: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
מאת: Gillies, R, et al.
יצא לאור: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
מאת: Findlay, J, et al.
יצא לאור: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
מאת: Gillies, R, et al.
יצא לאור: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
מאת: Gillies, R, et al.
יצא לאור: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
מאת: Gillies, R, et al.
יצא לאור: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
מאת: Findlay, J, et al.
יצא לאור: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
מאת: Teoh, S, et al.
יצא לאור: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
מאת: Chowdhury, F, et al.
יצא לאור: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
מאת: Millo, J, et al.
יצא לאור: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
מאת: Findlay, J, et al.
יצא לאור: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
מאת: Rana, M, et al.
יצא לאור: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
מאת: den Boer, RB, et al.
יצא לאור: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
מאת: John M. Findlay, et al.
יצא לאור: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
מאת: Gillies, R, et al.
יצא לאור: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
מאת: Kieran G. Foley, et al.
יצא לאור: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
מאת: Teoh, S, et al.
יצא לאור: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
מאת: Reem Yusuf AlBuainain, et al.
יצא לאור: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
מאת: Tarik Sengoz, et al.
יצא לאור: (2023-04-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
מאת: Chowdhury, F, et al.
יצא לאור: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
מאת: A. G. M. T. Powell, et al.
יצא לאור: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
מאת: Alexander M Th Schmitz, et al.
יצא לאור: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
מאת: Lihua Chen, et al.
יצא לאור: (2017-08-01)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
מאת: Turkington, RC, et al.
יצא לאור: (2019)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
מאת: Findlay, J, et al.
יצא לאור: (2019)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
מאת: Sun-pyo Hong, et al.
יצא לאור: (2024-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
מאת: M. K. Ibragimova, et al.
יצא לאור: (2022-03-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
מאת: Sangwon Han, et al.
יצא לאור: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
מאת: Narendra Pandit, et al.
יצא לאור: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
מאת: Inci Kizildag Yirgin, et al.
יצא לאור: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
מאת: Yao J, et al.
יצא לאור: (2021-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
מאת: M. K. Ibragimova, et al.
יצא לאור: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
מאת: Rui-Qin Zhou, et al.
יצא לאור: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
מאת: Giulia Polverari, et al.
יצא לאור: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
מאת: LU Shengnan, et al.
יצא לאור: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
מאת: Willard Wong, et al.
יצא לאור: (2021-07-01)

EVALUATİON OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY İN PATİENTS WİTH BREAST CANCER
מאת: Can Atalay, et al.
יצא לאור: (2007-01-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
מאת: P. V. Kazantseva, et al.
יצא לאור: (2016-07-01)